Policy Supported
Letters Supported & Letters Submitted
Group Sign On Letter in Support of the Copay Accumulator Ban Bill
ACSCAN-NY has delivered the group sign on letter (in support of the Copay Accumulator Ban Bill S.5299/A.1741) to leadership and the entire legislature. Now that the letter has been delivered, it’s time to take some action! Here are three things you can do right...
Comments regarding the CY 2023 Medicare Advantage and Part D Proposed Rule (CMS-4192-P)
Patients Rising Now supports to provisions on the proposed rule to lower out of pocket Medicare Part D prescription drug costs and improve transparency, the patient voice, and health equity in Medicare Advantage (MA) and Part D. Read the Comments Letter ...
Letter Supported: Opposition to any “Right to Repair” Legislation Honorable Michelle Mussman Illinois House of Representatives
As organizations dedicated to the health and safety of patients, we write to express our strong opposition to any “right to repair” legislation that would promote the substitution of highly qualified and certified repair operations with operations who aren’t required...
Letter Supported: Opposition to any “Right to Repair” Legislation Honorable Lamont J. Robinson, Jr. Chair, Cybersecurity, Data Analytics, & IT Committee
As organizations dedicated to the health and safety of patients, we write to express our strong opposition to any “right to repair” legislation that would promote the substitution of highly qualified and certified repair operations with operations who aren’t required...
Letter Submitted: Draft NCD for Monoclonal Antibodies Directed Against Amyloid for the treatment of Alzheimer’s Disease
We have serious concerns about CMS’s draft national coverage determination (NCD) – issued January 11, 2022 – to limit Medicare coverage for monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s Disease (AD) to patients enrolled in...
Patients Rising Now’s Comments on Oregon’s 1115 Waiver and Impact on Access
The FDA’s Accelerated Approval Program provides a path for earlier approval of drugs being developed to treat serious diseases and address unmet medical need. The process allows the use of a surrogate endpoint—an indirect marker of clinical benefit that allows the...
Letter in support of the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug Administration
On behalf of Patients Rising, the organization representing millions of Americans living with chronic disease, I write to support the nomination of Dr. Robert Califf to serve as Commissioner of the Food and Drug Administration. The U.S. Food and Drug Administration...
Letter Supported: Importance of Orphan Drug Tax Credit for People and Families Living with Autoimmune Disease
On behalf of the estimated 50 million Americans with autoimmune and immune-mediated diseases, the undersigned 64 organizations write to you regarding the importance of the Orphan Drug Tax Credit (ODTC) for people and families living with autoimmune disease and urge...
Letter Supported: Step Therapy for Part B Drugs in Medicare Advantage
The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, complex, chronic conditions and/or the physicians who care for them, are asking the Centers for Medicare and Medicaid Services (CMS) to ensure that beneficiaries...
Letter Supporting S.4111 Breslin/A.4668 Peoples-Stokes Prohibiting Non-medical Switching
This year S.4111 Breslin/A.4668 Peoples-Stokes overwhelmingly passed both the New York State Senate and Assembly with bipartisan support; a loud and unified message underscoring the importance of putting patients first. Once signed into law, this bill will prohibit...
Patient Community Concerns with Drug Pricing Proposals
We, the undersigned 46 organizations, on behalf of millions of American patients who live with complex, chronic health conditions such as HIV, autoimmune diseases, cancer, diabetes, lupus, multiple sclerosis, and hepatitis, are pleased that your committee and Congress...
Ban Co-pay Accumulator Programs in Massachusetts
Show your support for S. 644 and H.1053 which would ban co-pay accumulator programs in Massachusetts. Many Insurers and PBMs are now utilizing copay accumulators to stop copay assistance from counting towards a patient’s deductible and maximum out-of-pocket spending....